Ak-con
Loading...Ak-con Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Patients under therapy with MAO inhibitors may experience a severe hypertensive crisis if given a sympathomimetic drug. Use in children, especially infants, may result in CNS depression leading to coma and marked reduction in body temperature.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Naphazoline Hydrochloride Ophthalmic Solution is indicated for use as a topical ocular vasoconstrictor.
History
There is currently no drug history available for this drug.
Other Information
Naphazoline hydrochloride, an ocular vasoconstrictor, is an imidazoline derivative sympathomimetic amine. It occurs as a white, odorless crystalline powder having a bitter taste and is freely soluble in water and in alcohol. The active ingredient is represented by the structural formula:
2-(1-Naphthylmethyl)-2-imidazoline monohydrochloride
Active: naphazoline HCl 1 mg (0.1%). Preservative: benzalkonium chloride 0.1mg (0.01%).
Inactives: Boric acid; edetate disodium; purified water; sodium chloride; sodium carbonate; and hydrochloric acid may be added to adjust the pH (5.5 to 7.0).
Sources
Ak-con Manufacturers
-
Rebel Distributors Corp.
![Ak-con (Naphazoline Hydrochloride) Solution [Rebel Distributors Corp.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Ak-con | Rebel Distributors Corp.
Instill one or two drops in the conjunctival sac(s) every three to four hours as needed.
-
Preferred Pharmaceuticals, Inc.
Ak-con | Preferred Pharmaceuticals, Inc.
Instill one or two drops in the conjunctival sac(s) every three to four hours as needed.
![Ak-con (Naphazoline Hydrochloride) Solution/ Drops [Preferred Pharmaceuticals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8d353143-cd29-4a5f-9d67-293a6322e088&name=nap02-0000-02.jpg)
Login To Your Free Account